Jim Simons’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $284K | Sell |
105,500
-998,800
| -90% | -$2.58M | ﹤0.01% | 2793 |
|
|
2026
Q1 | $2.45M | Sell |
1,104,300
-380,178
| -26% | -$680K | ﹤0.01% | 1788 |
|
|
2025
Q4 | $2.42M | Sell |
1,484,478
-533,546
| -26% | -$822K | ﹤0.01% | 1746 |
|
|
2025
Q3 | $2.62M | Sell |
2,018,024
-77,285
| -4% | -$67K | ﹤0.01% | 1900 |
|
|
2025
Q2 | $691K | Buy |
2,095,309
+1,071,509
| +105% | +$323K | ﹤0.01% | 2678 |
|
|
2025
Q1 | $319K | Buy |
1,023,800
+916,100
| +851% | +$563K | ﹤0.01% | 2911 |
|
|
2024
Q4 | $101K | Buy |
107,700
+63,200
| +142% | +$70.7K | ﹤0.01% | 3285 |
|
|
2024
Q3 | $52.5K | Sell |
44,500
-96,700
| -68% | -$101K | ﹤0.01% | 3337 |
|
|
2024
Q2 | $109K | Sell |
141,200
-15,600
| -10% | -$43.4K | ﹤0.01% | 3168 |
|
|
2024
Q1 | $478K | Buy |
156,800
+105,600
| +206% | +$353K | ﹤0.01% | 2884 |
|
|
2023
Q4 | $165K | Sell |
51,200
-29,600
| -37% | -$101K | ﹤0.01% | 3191 |
|
|
2023
Q3 | $310K | Sell |
80,800
-33,900
| -30% | -$122K | ﹤0.01% | 2918 |
|
|
2023
Q2 | $376K | Sell |
114,700
-5,900
| -5% | -$20K | ﹤0.01% | 3022 |
|
|
2023
Q1 | $311K | Buy |
120,600
+800
| +0.7% | +$1.9K | ﹤0.01% | 3103 |
|
|
2022
Q4 | $223K | Buy |
119,800
+1,000
| +0.8% | +$1.7K | ﹤0.01% | 3368 |
|
|
2022
Q3 | $219K | Sell |
118,800
-5,000
| -4% | -$10.5K | ﹤0.01% | 3350 |
|
|
2022
Q2 | $266K | Buy |
123,800
+39,000
| +46% | +$94.2K | ﹤0.01% | 3521 |
|
|
2022
Q1 | $266K | Buy |
84,800
+26,200
| +45% | +$82.4K | ﹤0.01% | 3525 |
|
|
2021
Q4 | $188K | Buy |
58,600
+24,100
| +70% | +$82.6K | ﹤0.01% | 3531 |
|
|
2021
Q3 | $116K | Buy |
+34,500
| New | +$126K | ﹤0.01% | 3296 |
|
|
2021
Q1 | – | Sell |
-710,507
| Closed | -$1.64M | – | 3601 |
|
|
2020
Q4 | $1.64M | Buy |
+710,507
| New | +$3.31M | ﹤0.01% | 2244 |
|
|
2020
Q3 | – | Sell |
-624,109
| Closed | -$4.6M | – | 3595 |
|
|
2020
Q2 | $4.6M | Sell |
624,109
-228,734
| -27% | -$1.07M | ﹤0.01% | 1695 |
|
|
2020
Q1 | $2.54M | Sell |
852,843
-231,866
| -21% | -$781K | ﹤0.01% | 1936 |
|
|
2019
Q4 | $4.5M | Buy |
1,084,709
+497,984
| +85% | +$1.57M | ﹤0.01% | 1914 |
|
|
2019
Q3 | $1.9M | Buy |
586,725
+115,116
| +24% | +$262K | ﹤0.01% | 2307 |
|
|
2019
Q2 | $872K | Buy |
471,609
+108,392
| +30% | +$194K | ﹤0.01% | 2743 |
|
|
2019
Q1 | $643K | Buy |
363,217
+308,117
| +559% | +$771K | ﹤0.01% | 2848 |
|
|
2018
Q4 | $133K | Buy |
+55,100
| New | +$251K | ﹤0.01% | 3196 |
|
Other funds holding OVID
Jim Simons's OVID Position: Q2 2026 in Review
Jim Simons reduced its Ovid Therapeutics (OVID) stake by 90% in Q2 2026, selling an estimated $2.58M and leaving 105,500 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #2793.
Jim Simons first reported a position in OVID in Q4 2018 and has held it in 28 quarters since. The position peaked at $4.6M in Q2 2020. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.
- Jim Simons held 105,500 shares of Ovid Therapeutics worth $284K as of Q2 2026.
- Jim Simons sold 998,800 Ovid Therapeutics shares in Q2 2026, an estimated $2.58M.
- Ovid Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2793 holding.
- Jim Simons first reported a position in Ovid Therapeutics in Q4 2018 and has held it in 28 quarters since.
- Jim Simons's Ovid Therapeutics position peaked at $4.6M in Q2 2020.
- 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.